May 4, 2018 8:30am-2:30pm
In partnership with EY and Scientific American, Bioethics International is hosting a Forum on what it means to be a purpose driven, patient-centered and ethical pharma and health-innovation company.
Location: New York, NY
September 20, 2018 2:00-3:30pm
Public Accountability Around Disclosure
Merete Jørgensen, Senior Trial Disclosure Director, Clinical Reporting Anchor & Disclosure, Novo Nordisk, Denmark
Fiona Godlee, Editor in Chief, British Medical Journal (BMJ), United Kingdom
Jennifer Miller, Founder, Bioethics International and Good Pharma Scorecard, Assistant Professor, Yale University School of Medicine, United States of America
Lise Baltzer, Director for Global Publications, Novo Nordisk, Denmark
October 23, 2018 — October 24, 2018
The Milken Institute Future of Health Summit convenes thought leaders and decision makers to confront some of the world’s most significant health challenges.
Dr. Jennifer E. Miller, Founder of Bioethics International and Assistant Professor at Yale School of Medicine, will speak on the ethics and patient-centricity of healthcare innovation and the pharmaceutical sector.
July 18, 2018 10:45-11:30am
This panel will discuss the impact of evolving technologies on cybersecurity as well as issues around privacy, quantum computing & encryption, big data, machine learning and AI.
Jonathan Conrad, Chairman, CEO & Founder, AdmieMobile
Shahryar Shaghagi, National Leader of Cybersecurity, CohnReznick
Jennifer Miller, Assistant Professor, Yale School of Medicine; Founder, Bioethics International
Mark Jackson, Scientific Lead, Cambridge Quantum Computing
July 17, 2018 — July 18, 2018
These sessions will build on the strategies and tools discussed in the December 2017 Next Wave Forum – more details to come.
Location: Cambridge, MA
June 27, 2018 9:00-10:00am
Blockchain technology offers many things. But if all you know about blockchain is bitcoin, you might be surprised to hear it may offer pharma an opportunity for more trustworthiness and transparency. In this free webinar we’ll be going beyond privacy, beyond honesty, beyond trust. We’ll explore how new technology and contract innovation offers a route for each and every human being to take control of their own data as their own property. And how pharma companies might welcome this development with open arms.
June 5, 2018 — June 6, 2018
DECONSTRUCTING CLINICAL TRIALS: the core of drug development and company valuations
Keywords: investment risks, opaque clinical trials.
Speakers:
Jennifer E. Miller, Founder, Bioethics International; Yale
Bowen Gu, Investor Engagement Researcher, Access to Medicine Foundation
Helena Fiestas, BNP Paribas Asset Management
May 24, 2018 2:00-3:00pm
This webinar will cover access to innovative new therapies through expanded access programs with guest speakers Jennifer Miller, PhD, Assistant Professor at Yale University School of Medicine and Alison Bateman-House, PhD, MPH, Assistant Professor at NYU School of Medicine. The webinar will look in detail at the process involved in obtaining an investigational therapy before it gains final FDA approval. Open to anyone looking to learn more about expanded access programs. Register here:http://bit.ly/2I8UvK8
May 4, 2018 8:30am-2:30pm
In partnership with EY and Scientific American, Bioethics International is hosting a Forum on what it means to be a purpose driven, patient-centered and ethical pharma and health-innovation company.
Location: New York, NY
